MDB Insider Sales: 8,004 Shares Sold Recently; New Form 144 Filed
Rhea-AI Filing Summary
Form 144 filing by an insider related to MongoDB, Inc. (MDB) discloses a proposed sale of 664 common shares with an aggregate market value of $209,565.04, scheduled approximately for 09/02/2025 on NASDAQ. The shares were originally acquired on 10/01/2009 as a VC investment and paid for in cash. The filing also lists recent 10b5-1 sales on 08/28/2025 totaling 8,004 shares for gross proceeds of $2,400,000 (6,668 shares by Charles M. Hazard Jr. for $2,000,400 and 1,336 shares by The Narragansett Bay Childrens Trust for $400,800). The filer certifies under Rule 144 statements about material nonpublic information and references any applicable 10b5-1 trading plan.
Positive
- Proper regulatory compliance: The filer submitted a Rule 144 notice with acquisition details and 10b5-1 disclosures.
- Transparency on provenance: Acquisition date (10/01/2009) and cash payment are disclosed, clarifying the holding origin.
Negative
- Insider selling activity: Recent 10b5-1 sales on 08/28/2025 totaled 8,004 shares for $2,400,000 in gross proceeds.
Insights
TL;DR: Insider sale notice for a small block of shares; recent 10b5-1 activity shows modest monetization by related parties.
The filing shows a proposed Rule 144 sale of 664 shares valued at about $209.6k and discloses 10b5-1 sales on 08/28/2025 totaling 8,004 shares for $2.4M in gross proceeds. Relative to the 81,356,893 shares outstanding noted in the filing, these transactions represent a de minimis percentage of the float and are unlikely to change company control or capital structure. The inclusion of acquisition details (10/01/2009 VC investment) and the 10b5-1 sales offers transparency on the provenance of shares and timing. For investors, this is routine insider liquidity rather than evidence of company operational change.
TL;DR: Properly filed Rule 144 notice with 10b5-1 disclosures; governance procedures appear followed.
The filer affirms the absence of undisclosed material adverse information and references Rule 10b5-1 trading instructions where applicable. The documentation of acquisition date, payment method, and relation to the issuer aligns with regulatory expectations. The recent 10b5-1 sales by named parties are disclosed with gross proceeds, supporting compliance and transparency. No departures from standard disclosure or governance controls are apparent within this filing's content.